Hypertension. 2008;51:811-816
Published online before print March 10, 2008,
doi: 10.1161/HYPERTENSIONAHA.105.063636
(Hypertension. 2008;51:811.)
© 2008 American Heart Association, Inc.
Kidney in Hypertension
Guyton Redux
Thomas M. Coffman;
Steven D. Crowley
From the Division of Nephrology, Department of Medicine, Duke University and Durham VeteransAffairs Medical Centers, Durham, NC.
Correspondence to Thomas M. Coffman, Room 2018 MSRB2, 106 Research Dr, Duke University Medical Center, Durham, NC 27710. E-mail tcoffman@duke.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
Regulation of blood pressure is a complex integrated response
involving a variety of organ systems including the central nervous
system (CNS), cardiovascular system, kidneys, and adrenal glands.
These systems modulate cardiac output, fluid volumes, and peripheral
vascular resistance, the key determinants of blood pressure.
More than 40 years ago, Guyton and Coleman
1 developed computer
models of arterial pressure control, attempting to incorporate
the known variables impacting blood pressure homeostasis. The
conclusion of this analysis was that regulation of sodium excretion
by the kidney and consequent effects on body fluid volumes made
up the critical pathway determining the chronic level of intra-arterial
pressure.
 |
The Renin-Angiotensin System and Blood Pressure Control
|
|---|
Our own studies of the physiology of blood pressure regulation
have focused on the renin-angiotensin (Ang) system (RAS) using
genetically modified mouse models. Highly conserved through
phylogeny, the RAS is an essential regulator of blood pressure
and fluid balance. This biological system is a multienzymatic
cascade in which angiotensinogen, its major substrate, is processed
in a 2-step reaction by renin and Ang-converting enzyme (ACE),
resulting in the sequential generation of Ang I and Ang II.
Along with its importance in maintaining normal circulatory
homeostasis, abnormal activation of the RAS can contribute to
the development of hypertension and target organ damage. The
importance of the RAS in clinical medicine is highlighted by
the impressive efficacy of pharmacological agents that inhibit
the synthesis or activity of Ang II.
2–5
At the cellular level, responsiveness to Ang II is conferred by expression of Ang receptors. Ang receptors can be divided into 2 . . . [Full Text of this Article]
This article has been cited by other articles:

|
 |

|
 |
 
D. Zhao, D. M. Seth, and L. G. Navar
Enhanced Distal Nephron Sodium Reabsorption in Chronic Angiotensin II-Infused Mice
Hypertension,
July 1, 2009;
54(1):
120 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Fink
Sympathetic Activity, Vascular Capacitance, and Long-Term Regulation of Arterial Pressure
Hypertension,
February 1, 2009;
53(2):
307 - 312.
[Full Text]
[PDF]
|
 |
|